UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
Daily State of the Markets 02/07: Irrelevant?
-
Daily State of the Markets 10/04: Pressing Pause (Again)
-
UBS Downgrades Zymogenetics (ZGEN) to Neutral; Acquired By Bristol-Myers (BMY)
-
Notable Analyst Rating Changes 08/31: GPS, ANF, BMY, UBS Upgraded; HPQ, DGIT, RAX, POT Downgraded
-
Notable Analyst Rating Changes 06/11: SQNM, SVVS, BMY, X Upgraded; LGF, AGU, WAG, THO Downgraded
-
UBS Maintains a 'Neutral' Rating on Bristol-Myers (BMY); Lowers PT
-
Notable Analyst Rating Changes: MS, BA, UNH, INTC, UPL, FTO, More Upgraded; BMY, CHK, BSX, MELI, More Downgraded
-
Notable Analyst Rating Changes 12/22: ATHX, IAG, BUCY, AMTD Upgraded; XTO, IMAX, WRC Downgraded
-
Notable Analyst Rating Changes 8/28: JCG, WSM, NOK, ARUN Upgraded; POT, MOS, BA, ENER, BMY Downgraded
-
David Moenning�s Daily State of the Markets: 8/28
-
Unusual 11 Mid-Day Movers 7/23: SOMX, MEDX, VCI, CERS Higher; RPRX, SPAR, CRA, FREE Lower
-
Notable Analyst Rating Changes 7/15: GS, ALU, ICE, MCO, ADBE, MI Upgraded; PTR, PAR, UFS, PCL Downgraded
-
David Moenning's Daily State of the Markets: 4/28
-
Trading Radar for 4/28: Bristol-Myers Squibb (BMY), Pfizer (PFE), BP (BP), Sun Micro (JAVA), Deutsche Bank (DB), E*TRADE (ETFC), Level 3 (LVLT) Report; Consumer Confidence Due
-
FDA Requests Pharmacokinetic Study Additional ImClone (LLY) and Bristol-Myers (BMY) in Response Letter for ERBITUX
-
Mead Johnson (MJN) IPO Looks On Track
-
Reports Sanofi-Aventis (SNY) On The Prowl For Mergers
-
David Moenning's Daily State of the Markets: 1/27
-
ImClone (LLY) and Bristol-Myers (BMY) Decide to Withdraw sBLA for EREBITUX to Treat Advanced Non-Small Cell Lung Cancer
-
Morning Movers 1/13: ZymoGenetics (ZGEN) Up On Bristol-Myers Deal; Lexmark (LXK) Down On Guidance
-
David Moenning's Daily State of the Markets: 12/10
-
Notable Analyst Rating Changes 12/10: RTP, BMY, HE Upgraded; GE, NUE, EBAY, ERTS Downgraded
-
Notable Analyst Rating Changes 11/07: ANF, TWTC, CECEO Upgraded; TM, DLB, SI Downgraded
-
David Moenning's Daily State of the Markets: 10/23
-
Trading Radar for 10/23: Microsoft (MSFT), Altria (MO), UPS (UPS), Dow (DOW), Bristol-Myers (BMY), Eli Lilly (LLY), Potash (POT), MEMC Electronic (WFR), Level 3 (LVLT) Report
-
Top 10 News Items 10/6-10/10: Dow Plunges 18% This Week; UK to Inject Capital Into Banking System; Iceland Melts-down, Seizes Largest Bank
-
Notable Mergers and Acquisitions of the Day 9/29: C/WB, IMCL, VSH/IRF
-
Pre-Open Movers 9/23: ImClone (IMCL) Up on Raised Bid; Cache (CACH) Sinks On Lower Guidance
-
Mead Johnson Nutrition (MJN) Files $1B IPO
-
Trading Radar 4/24: Microsoft (MSFT), Potash (POT), Ford (F), Baidu (BIDU), Pepsi (PEP), Altria (MO), Motorola (MOT), 3M (MMM) Report; Initial Jobless Claims, New Home Sales, Durable Goods Due
-
David Moenning's Daily State of the Markets:
